Text Size

Pre-ESRD Syndrome in High Risk African Americans

This study has been terminated.
(Only apx 1/3 of enrolled subjects (signed consent) participated. Futility analysis to show primary endpoint)
Sponsor:
Information provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
ClinicalTrials.gov Identifier:
NCT00224939
First received: September 21, 2005
Last updated: January 12, 2010
Last verified: January 2010
History of Changes
  Purpose

Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.


Condition Intervention
Blood Pressure
 Drug: Potassium Chloride

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double-Blind
Primary Purpose: Prevention
Official Title: Pre-ESRD Syndrome in High Risk African American Young Adults

Resource links provided by NLM:

MedlinePlus related topics: Potassium
U.S. FDA Resources

Further study details as provided by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK):

Estimated Enrollment: 144
Study Start Date: July 2002
Study Completion Date: December 2006
Detailed Description:

Evaluation of the dipping status of blood pressure (wether blood pressure decreases at night) and renal functional reserve and wether non-dippers (those whose blood pressure does not decrease at night) can be modulated to dippers with potassium treatment.

  Eligibility

Ages Eligible for Study:   18 Years to 35 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria: 18-35, healthy volunteers, African American

Exclusion Criteria: Active medical conditions, prescription drug therapy other than birth control

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00224939

Locations
United States, Virginia
Virginia Commonwealth University
Richmond, Virginia, United States, 23298
Sponsors and Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Investigators
Principal Investigator: Elizabeth B Ripley, MD Virginia Commonwealth University
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00224939     History of Changes
Other Study ID Numbers: DK 62714 (terminated)
Study First Received: September 21, 2005
Last Updated: January 12, 2010
Health Authority: United States: Federal Government

ClinicalTrials.gov processed this record on May 23, 2013